Acadia Pharmaceuticals (ACAD US)

Analysis

Health Care • United States

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Refresh

Company Presentation • 13 Oct 2026 12:23

Corporate presentation

Company Presentation • 24 Sep 2026 20:00

Study result

Company Presentation • 05 Aug 2026 04:30

Q2 2026

Company Presentation • 12 May 2016 05:20

Bank of America Merrill Lynch 2016 Healthcare Conference

Company Presentation • 11 Jan 2017 05:30

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corporate presentation

Study result

Q2 2026

Bank of America Merrill Lynch 2016 Healthcare Conference

35th Annual JP Morgan Healthcare Conference